Jiafu Ji Selected Research

Jiafu Ji Research Topics

Disease

126	Stomach Neoplasms (Stomach Cancer) 06/2022 - 12/2002
109	Neoplasms (Cancer) 10/2022 - 02/2004
27	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2002
17	Carcinoma (Carcinomatosis) 01/2021 - 09/2002
13	Adenocarcinoma 12/2021 - 12/2002
12	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 03/2006
9	Carcinogenesis 01/2021 - 01/2012
6	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2014
4	Pancreatic Neoplasms (Pancreatic Cancer) 06/2021 - 03/2016
4	Colonic Neoplasms (Colon Cancer) 01/2016 - 03/2006
4	Lymphatic Metastasis 05/2014 - 03/2006
3	Microsatellite Instability 10/2022 - 03/2016
3	Inflammation (Inflammations) 03/2021 - 03/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 06/2017
3	Infections 12/2020 - 11/2017
3	Rectal Neoplasms (Rectal Cancer) 01/2020 - 04/2017
3	Anastomotic Leak 08/2016 - 01/2016
2	COVID-19 02/2022 - 04/2021
2	Lung Neoplasms (Lung Cancer) 09/2021 - 08/2021
2	Disease Progression 06/2021 - 10/2016
2	Margins of Excision 04/2021 - 06/2012
2	Neuroblastoma 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2018 - 10/2015
2	Vomiting 04/2016 - 09/2015
2	Nausea 04/2016 - 09/2015
2	Gastritis 06/2012 - 01/2012
1	Diarrhea 02/2022
1	Flatulence 02/2022
1	Insulin Resistance 01/2022
1	Residual Neoplasm 01/2022
1	Necrosis 01/2022

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2004
21	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2007
12	Messenger RNA (mRNA)IBA 01/2022 - 01/2003
10	Pharmaceutical PreparationsIBA 04/2022 - 02/2016
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2012
9	Biological ProductsIBA 01/2021 - 02/2013
7	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 01/2014
7	CateninsIBA 12/2021 - 01/2017
6	RNA (Ribonucleic Acid)IBA 12/2021 - 06/2017
6	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2012
5	Phosphotransferases (Kinase)IBA 06/2021 - 02/2013
4	Long Noncoding RNAIBA 01/2022 - 01/2019
4	Trastuzumab (Herceptin)FDA Link 08/2021 - 01/2013
4	Indicators and Reagents (Reagents)IBA 01/2019 - 02/2013
4	yangzheng xiaojiIBA 09/2015 - 07/2012
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 09/2018
3	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2012
3	LigandsIBA 01/2021 - 02/2014
3	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 01/2012
3	Calcibiotic Root Canal SealerIBA 01/2018 - 03/2006
3	hydrogen sulfite (bisulfite)IBA 09/2014 - 01/2012
3	Complementary DNA (cDNA)IBA 08/2003 - 09/2002
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2017
2	InterleukinsIBA 01/2022 - 03/2016
2	PlatinumIBA 12/2021 - 08/2016
2	Tumor Biomarkers (Tumor Markers)IBA 07/2021 - 01/2014
2	Small Interfering RNA (siRNA)IBA 04/2021 - 05/2013
2	ProteomeIBA 01/2021 - 01/2018
2	tdTomatoIBA 01/2020 - 01/2020
2	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 01/2020
2	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2019
2	MicellesIBA 01/2019 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2019 - 09/2008
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 02/2013
2	Leucine (L-Leucine)FDA Link 01/2019 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2018
2	AntigensIBA 10/2017 - 05/2009
2	ParaffinIBA 10/2017 - 02/2004
2	Formaldehyde (Formol)FDA Link 10/2017 - 02/2004
2	Cetuximab (Erbitux)FDA Link 10/2017 - 10/2013
2	Cysteine (L-Cysteine)FDA Link 06/2017 - 11/2016
2	Adenylate KinaseIBA 01/2017 - 01/2017
2	CytokinesIBA 01/2016 - 10/2014
2	TOR Serine-Threonine KinasesIBA 11/2014 - 02/2013
2	MTOR InhibitorsIBA 11/2014 - 02/2013
1	Therapeutic UsesIBA 02/2022
1	Insulin (Novolin)FDA Link 01/2022
1	maltodextrinIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022

Therapy/Procedure

47	Gastrectomy 12/2021 - 01/2012
34	Therapeutics 04/2022 - 04/2010
29	Neoadjuvant Therapy 01/2022 - 08/2012
28	Drug Therapy (Chemotherapy) 04/2022 - 07/2012
12	Adjuvant Chemotherapy 12/2021 - 03/2008
11	Lymph Node Excision (Lymph Node Dissection) 12/2021 - 04/2014
6	Immunotherapy 10/2022 - 01/2020
4	Precision Medicine 04/2022 - 01/2016
4	Length of Stay 02/2022 - 02/2009
2	Proctectomy 01/2022 - 01/2020
2	Chemoradiotherapy 01/2020 - 09/2018
2	Hyperthermic Intraperitoneal Chemotherapy 01/2016 - 06/2015
2	Cytoreduction Surgical Procedures 01/2016 - 06/2015
1	Moxibustion 02/2022
1	Oral Administration 01/2022